drugset / Trial / NCT04042974

Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients

NCT04042974

Phase 4 Unknown 100 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the effectiveness of vaginal dinoprostone with placebo in minimizing the pain experienced by primarily infertile patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.

Timeline

Start
2019-08-10
Primary completion
2019-11-10
Completion
2019-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Dinoprostone Other / unclassified 3 mg Intravenous

Indications

No indication recorded.